JPRN-jRCT2080224025已完成2 期
A Phase IIa, Randomised, Parallel, Double-Blind,Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MEDI0382 in Japanese Preobese or Obese Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control with Diet and Exercise
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Individuals whose HbA1c range of 7.0% to 10.5% (inclusive) at screening
- •- Individuals who are diagnosed with T2DM
- •- Individuals whose current condition at enrolment (Visit 1) is drug naive
- •- BMI within the range of 24 - 40 kg/m2 (inclusive) at screening
排除标准
- •- Subjects with any of the following results at screening:
- •Aspartate transaminase (AST) 2.5 X upper limit of normal (ULN) or more
- •Alanine transaminase (ALT) 2.5 X ULN or more
- •Total bilirubin (TBL) 2 X ULN or more
- •Impaired renal function defined as estimated glomerular filtration rate (eGFR) 60 mL/minute/1.73 m2 or less at screening
- •- Participation in another clinical study with an investigational product administered in the last 30 days or 5 half-lives of the drug (whichever is longer) at the time of screening
研究者
相似试验
招募中
1 期
Study of M5049 in DM and PM Participants (NEPTUNIA)CTIS2022-501351-82-00Merck Healthcare KGaA41
进行中（未招募）
不适用
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgiaPosttraumatic Neuralgia (neuropathic pain)MedDRA version: 14.1Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-019785-90-SEAstraZeneca AB135
进行中（未招募）
1 期
A Phase IIa, Double-blind, Randomised, Parallel-group, Multi-centre Study to Evaluate the Analgesic Efficacy of 28 Days Oral Administration of AZD2423 Compared to Placebo in Patients with Posttraumatic NeuralgiaPosttraumatic Neuralgia (neuropathic pain)MedDRA version: 12.1Level: LLTClassification code 10054095Term: Neuropathic painEUCTR2010-019785-90-FRAstraZeneca AB135
进行中（未招募）
不适用
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgiaPosttraumatic Neuralgia (neuropathic pain)MedDRA version: 14.0Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-019785-90-GBAstraZeneca AB135
进行中（未招募）
不适用
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgiaEUCTR2010-019785-90-DKAstraZeneca AB135